Health-related quality of life in patients with prominent negative symptoms: results from a multicenter randomized Phase II trial on bitopertin

被引:0
作者
Diana Rofail
Antoine Regnault
Stéphanie le Scouiller
Carmen Galani Berardo
Daniel Umbricht
Ray Fitzpatrick
机构
[1] Roche Products LTD,
[2] Mapi,undefined
[3] HEOR & Strategic Market Access,undefined
[4] F Hoffmann – La Roche,undefined
[5] University of Oxford,undefined
来源
Quality of Life Research | 2016年 / 25卷
关键词
Quality of life; Schizophrenia; Negative symptoms; Bitopertin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:201 / 211
页数:10
相关论文
共 117 条
[1]  
McCabe R(2007)Patient-reported outcomes in schizophrenia British Journal of Psychiatry. Supplement 50 s21-s28
[2]  
Saidi M(2003)Quality of life in schizophrenia: A grounded theory approach Health and Quality of Life Outcomes 1 31-645
[3]  
Priebe S(2009)Schizophrenia Lancet 374 635-213
[4]  
Gee L(2009)Physical and mental health-related quality of life among older people with schizophrenia Schizophrenia Research 108 207-46
[5]  
Pearce E(2000)Self-report quality of life measure for people with schizophrenia: The SQLS British Journal of Psychiatry 177 42-306
[6]  
Jackson M(2013)Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE) Acta Neuropsychiatrica 25 297-107
[7]  
van Os J(2007)Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: A comparative cross-sectional study International Journal of Social Psychiatry 53 99-594
[8]  
Kapur S(2002)Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat Neuropsychopharmacology 26 583-57
[9]  
Folsom DP(2010)Effect of second-generation antipsychotics on cognition: Current issues and future challenges Expert Review of Neurotherapeutics 10 43-41
[10]  
Depp C(2009)Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis Lancet 373 31-23